Clinical Trials
NeuroSense initiates clinical studies to evaluate benefit of PrimeC for ALS patients
NeuroSense Therapeutics, a biotech company developing PrimeC, a combination drug which aims to slow or halt ALS progression, announced the initiation of two clinical studies to evaluate the benefit of PrimeC for ALS patients.
A phase IIa study is being...
Press Releases
Silgan Dispensing Highlights Solutions to Deliver a Better Healthcare Dispensing Experience at Pharmapack Conference
Silgan Dispensing, a global leader in the design, development, and distribution of highly engineered pumps and sprayers in the healthcare, home and personal care markets, will share insights and solutions aimed at delivering a better dispensing experience for patients...
Press Releases
Will PAT proliferation have a positive impact on global health?
Process analytical technology (PAT) has long been recognized in manufacturing as an effective automated quality assurance tool. Used in pharma small molecule & biotech applications, it is increasing process effectiveness and productivity while reducing batch-testing requirements and minimizing waste....
IT & Data Management
The digital twin is here – and you may be closer than you think to having one
The global importance of plastic-based medical and drug delivery devices is increasing the business opportunities for those in the medical plastics market. The opportunities to improve competitiveness offered by the fourth industrial revolution (Industry 4.0) will help those medical...
Clinical Trials
Sharp Clinical broadens global client support with Business Development appointments
Sharp Clinical Services, a part of UDG Healthcare and a leading provider of global clinical supply services, has added three key members to its business development team.
Katie Bracaliello, Johannes Stein and Olivier Cena have joined Sharp Clinical Services as...
Press Releases
Clinerion becomes EHDEN certified, supporting the building of a federated health data network in Europe
Clinerion has been certified by EHDEN (European Health Data & Evidence Network) to map health data from various formats to the OMOP common data model.
As an OMOP ambassador, Clinerion will support the speeding up of the process to map...
Drug Research
Grey Wolf completes £2.5m Series A2 financing for development of therapies targeting ERAP2
Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therapies for immuno-oncology (IO), announces it has completed a £2.5 million ($3.3 million) Series A2 financing round with existing leading international healthcare investors Andera Partners and Canaan.
The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read